In 2022, Eric Ostertag, M.D., Ph.D. earned $461.02K in total compensation at Poseida Therapeutics, Inc., primarily from $448.31K salary. Most recently acquired 142,857 shares in Aug 2022. Has donated $1.36M in stock to charitable causes. Led Poseida Therapeutics, Inc. as CEO for 3 years.
Compensation History
Annual executive compensation data for Eric Ostertag, M.D., Ph.D., including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$461.02K
Salary
$448.31K
Bonus
$0.00
Other
$12.71K
Salary
$448.31KBoard Justification
The compensation philosophy aligns with company performance and peer benchmarking, focusing on retention strategies for key executives.
Bonus
$0.00Board Justification
Dr. Ostertag was no longer eligible for a performance bonus after transitioning to Executive Chairman in February 2022.
Other Compensation
$12.71KBoard Justification
Other compensation includes 401(k) matching contributions and life insurance premiums.
Restricted Stock
Board Justification
No stock was vested in 2022 as he transitioned to Executive Chairman and did not receive stock grants during this period.
Performance Metrics
Performance metrics were not applicable for Dr. Ostertag in 2022 as he was no longer eligible for performance-based bonuses.
Eric Ostertag, M.D., Ph.D.
Founder and Ex-CEO of Poseida Therapeutics, Inc.
Education
M.D. and Ph.D. from the University of California, San Diego
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1972 - 53 years ago
CEO of Poseida Therapeutics, Inc. for
3 years 1 month (Jan 2019 - Feb 2022)
Previous Experience
Co-founder and CEO of Poseida Therapeutics, Inc.
Other Poseida Therapeutics, Inc. CEOs
Holdings
Track Eric Ostertag, M.D., Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$8.07M
$8.07M
950,066 PSTX shares
What if they kept their stock?
If Eric Ostertag, M.D., Ph.D. didn't sell their stock, today they would have:
Extra PSTX950,066 shares worth $9.03M.
This is 11.87% and $957.41K more than what they got when they sold the stock.
Charitable Transactions
142,857 shares
PSTX
Recent Charitable Transactions
142,857 shares
PSTX
Feb 1, 2022
Charity
Insider Trading
Eric Ostertag, M.D., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$500.00K
PSTX at $3.50/share
Aug 8, 2022
Purchase
$592.81K
PSTX at $3.69/share
Aug 3, 2022
Sale
89,500 shares
PSTX
Feb 1, 2022
Received
142,857 shares
PSTX
Feb 1, 2022
Charity
$134.17K
PSTX at $7.09/share
Nov 8, 2021
Sale
$140.60K
PSTX at $7.02/share
Oct 1, 2021
Sale
$160.02K
PSTX at $8.00/share
Sep 20, 2021
Sale
$162.71K
PSTX at $8.14/share
Sep 13, 2021
Sale
$944.25K
PSTX at $8.40/share
Sep 1, 2021
Sale
$271.40K
PSTX at $8.06/share
Aug 2, 2021
Sale
Rivals
Compare Eric Ostertag, M.D., Ph.D. with competitor CEOs and industry peers.